Pacer Advisors, Inc. Charles River Laboratories International, Inc. Transaction History
Pacer Advisors, Inc.
- $40.5 Billion
- Q4 2024
A detailed history of Pacer Advisors, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 4,086 shares of CRL stock, worth $615,024. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,086
Previous 5,367
23.87%
Holding current value
$615,024
Previous $1.06 Million
28.67%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
49.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$927 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$766 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$328 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$272 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$272 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.66B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...